184 related articles for article (PubMed ID: 16121583)
1. Dose perturbations due to contrast medium and air in mammosite treatment: an experimental and Monte Carlo study.
Cheng CW; Mitra R; Li XA; Das IJ
Med Phys; 2005 Jul; 32(7):2279-87. PubMed ID: 16121583
[TBL] [Abstract][Full Text] [Related]
2. Dose perturbations due to contrast medium and air in MammoSite
Cheng CW; Mitra R; Allen Li X; Das IJ
Med Phys; 2005 Jul; 32(7Part1):2279-2287. PubMed ID: 28493571
[TBL] [Abstract][Full Text] [Related]
3. Contrast effects on dosimetry of a partial breast irradiation system.
Kassas B; Mourtada F; Horton JL; Lane RG
Med Phys; 2004 Jul; 31(7):1976-9. PubMed ID: 15305449
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric perturbations due to an implanted cardiac pacemaker in MammoSite(®) treatment.
Sung W; Kim S; Kim JI; Lee JG; Shin YJ; Jung JY; Ye SJ
Med Phys; 2012 Oct; 39(10):6185-91. PubMed ID: 23039656
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional quantitative dose reduction analysis in MammoSite balloon by Monte Carlo calculations.
Zhang Z; Parsai EI; Feldmeier JJ
J Appl Clin Med Phys; 2007 Nov; 8(4):139-151. PubMed ID: 18449153
[TBL] [Abstract][Full Text] [Related]
6. Dose perturbation induced by radiographic contrast inside brachytherapy balloon applicators.
Kirk MC; Hsi WC; Chu JC; Niu H; Hu Z; Bernard D; Dickler A; Nguyen C
Med Phys; 2004 May; 31(5):1219-24. PubMed ID: 15191312
[TBL] [Abstract][Full Text] [Related]
7. On the use of HDR 60Co source with the MammoSite radiation therapy system.
Baltas D; Lymperopoulou G; Zamboglou N
Med Phys; 2008 Dec; 35(12):5263-8. PubMed ID: 19175085
[TBL] [Abstract][Full Text] [Related]
8. Investigation of source position uncertainties & balloon deformation in MammoSite brachytherapy on treatment effectiveness.
Bensaleh S; Bezak E
Australas Phys Eng Sci Med; 2010 Mar; 33(1):35-44. PubMed ID: 20300986
[TBL] [Abstract][Full Text] [Related]
9. Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator.
Hepel JT; Hiatt JR; Cardarelli GA; Wazer DE
Brachytherapy; 2010; 9(1):81-5. PubMed ID: 19850533
[TBL] [Abstract][Full Text] [Related]
10. Effects of breast-air and breast-lung interfaces on the dose rate at the planning target volume of a MammoSite catheter for Yb-169 and Ir-192 HDR sources.
Cazeca MJ; Medich DC; Munro JJ
Med Phys; 2010 Aug; 37(8):4038-45. PubMed ID: 20879565
[TBL] [Abstract][Full Text] [Related]
11. Dose reduction study in vaginal balloon packing filled with contrast for HDR brachytherapy treatment.
Saini AS; Zhang GG; Finkelstein SE; Biagioli MC
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1263-7. PubMed ID: 20950949
[TBL] [Abstract][Full Text] [Related]
12. The impact of uncertainties associated with MammoSite brachytherapy on the dose distribution in the breast.
Bensaleh S; Bezak E
J Appl Clin Med Phys; 2011 Nov; 12(4):3464. PubMed ID: 22089003
[TBL] [Abstract][Full Text] [Related]
13. Measurements of dose discrepancies due to inhomogeneities and radiographic contrast in balloon catheter brachytherapy.
Oh S; Scott J; Shin DH; Suh TS; Kim S
Med Phys; 2009 Sep; 36(9):3945-54. PubMed ID: 19810467
[TBL] [Abstract][Full Text] [Related]
14. Dose modification factor analysis of multilumen balloon brachytherapy applicator with Monte Carlo simulation.
Pearson D; Williams EA
J Appl Clin Med Phys; 2013 May; 15(3):54–62. PubMed ID: 24892326
[TBL] [Abstract][Full Text] [Related]
15. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
[TBL] [Abstract][Full Text] [Related]
16. [Dosimetric verification of MammoSite treatment plans using Monte Carlo simulations and measurements with a 2D ionization chamber array].
Budde M; Adamietz IA; Sommer H; Hermani H
Z Med Phys; 2018 Apr; 28(2):158-163. PubMed ID: 29033292
[TBL] [Abstract][Full Text] [Related]
17. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
[TBL] [Abstract][Full Text] [Related]
18. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
Mille MM; Xu XG; Rivard MJ
Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
[TBL] [Abstract][Full Text] [Related]
19. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
Poon E; Verhaegen F
Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
[TBL] [Abstract][Full Text] [Related]
20. Review of MammoSite brachytherapy: advantages, disadvantages and clinical outcomes.
Bensaleh S; Bezak E; Borg M
Acta Oncol; 2009; 48(4):487-94. PubMed ID: 19031175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
